{
  "trial_id": "NCT02313870",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Subjects aged 18 years old or more",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Patients affiliated to social security system,",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Bullous pemphigoid diagnosed according to the following criteria: presence of at least 3 of the 4 clinical criteria for bullous pemphigoid as published by the french group for study of blistering diseases (positive predictive value: 95 %: age over 70 years, no lesions on neck or head, absence of atrophic scars, no mucosal lesions.",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Histological Examination consistent with BP diagnosis and carried out in the month containing neutrophils and / or eosinophils associated with a dermal infiltrate consisting of neutrophils and / or eosinophils, or to margination of neutrophils and / or eosinophils along the dermoepidermal junction.",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Direct immunofluorescence performed C3 along the dermo-epidermal junction.",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Patients: no prior topical steroid or superpotent topical steroids for less than 16 days using the same or equivalent dosage as the one used in the study a different regimen and this regardless of the clinical resultsOR receiving potent or superpotent topical steroids for at least 16 days with a different regimen than that used during the trial AND not controlled by this treatment (appearance of at least 3 new blisters per day)",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "written consent of the patient or, if not possible, certified by a third party,",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "effective contraception (oral or intrauterine device) set up at least one month before For women of reproductive age (age <50 years), negative serum pregnancy test at inclusion.",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Serum albumin \u2265 25 g / L",
      "label": "met",
      "evidence": ""
    }
  ],
  "exclusion": [
    {
      "criterion": "Localized bullous pemphigoid (area <400 cm2: 20 x 20 cm)",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Major blood cytopenia: Hb \u2264 10 g / dl and / or leukocytes \u2264 3000 / mm3 and / or platelets \u2264 100,000 / mm3",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Creatinine Clearance appreciated by the formula MDRD <30 ml / min",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Serum albumin <25 g / L",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "pregnancy-associated Pemphigoid",
      "label": "not_met",
      "evidence": ""
    }
  ],
  "notes": "",
  "_meta": {
    "topic_id": "10",
    "trial_id": "NCT02313870",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}